氨甲环酸在择期颅内肿瘤切除术中的应用:系统综述
该系统综述遵循PRISMA指南,纳入4项研究共682例择期颅内肿瘤切除术患者,其中2项前瞻性队列研究、1项回顾性队列研究、1项病例系列。汇总数据χ2检验显示,使用氨甲环酸(TXA)的患者术中输血需求显著降低(比值比0.6273,95%CI 0.4254-0.9251,P=0.018);TXA组平均总失血量为821.9 mL,对照组为1099.0 mL;两组术后血红蛋白均值均为11.4 g/dL,无显著差异。结论支持术中TXA用于肿瘤切除,但其在肿瘤切除中的作用研究较其他神经外科领域少。
要点
- 汇总4项研究682例患者,TXA组术中输血需求显著降低(OR 0.6273,95%CI 0.4254-0.9251,P=0.018)。
- TXA组平均总失血量821.9 mL,对照组1099.0 mL。
- 两组术后血红蛋白均值均为11.4 g/dL,无显著差异。
核心结论
- 结果支持术中TXA用于颅内肿瘤切除术,但其在肿瘤切除中的作用研究较其他神经外科领域少。
研究设计与样本
- 遵循PRISMA指南的系统综述,纳入4篇文章共682例患者,包括2项前瞻性队列研究、1项回顾性队列研究、1项病例系列。
主要发现
- 汇总数据χ2检验显示,使用TXA的患者术中输血需求显著降低(OR 0.6273,95%CI 0.4254-0.9251,P=0.018)。
- 各研究中TXA组平均总失血量为821.9 mL,对照组为1099.0 mL。
- 两组术后血红蛋白均值均为11.4 g/dL,无显著差异。
关键数值与推荐
- TXA组术中输血需求较对照组显著降低(OR 0.6273,95%CI 0.4254-0.9251,P=0.018)。
- TXA组平均总失血量821.9 mL vs 对照组1099.0 mL。
- TXA组与对照组术后血红蛋白均值均为11.4 g/dL,无显著差异。
临床怎么用
- 原文结论支持术中TXA用于颅内肿瘤切除术,并指出其在肿瘤切除中的研究较其他神经外科领域少。
局限性
- 原文指出TXA在肿瘤切除中的作用研究较其他神经外科领域少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As an established antifibrinolytic agent, tranexamic acid (TXA) has garnered widespread use during surgery to limit intraoperative blood loss. In the field of neurosurgery, TXA is often introduced in cases of traumatic brain injury or elective spine surgeries; however, its role during elective cranial surgeries is not well established. We report a systematic review of the use of TXA in elective surgical resection of intracranial neoplasms. METHODS: We performed this systematic review following PRISMA guidelines to identify studies investigating the use of TXA in elective neurosurgical resection of intracranial neoplasms. Variables extracted included patient demographics, surgical indications, type of surgery performed, TXA dose and route of administration, operative duration, blood loss, transfusion rate, postoperative hemoglobin level, and complications. RESULTS: After careful screening, 4 articles (consisting of 682 patients) met our inclusion/exclusion criteria. The studies included 2 prospective cohort studies, 1 retrospective cohort study, and 1 case series. A χ2 test of pooled data demonstrated that patients administered TXA had a significantly decreased need for blood transfusions during surgery (odds ratio, 0.6273; 95% confidence interval, 0.4254-0.9251; P = 0.018). Mean total blood loss was 821.9 mL in the TXA group and 1099.0 mL in the control group across the studies. There was no significant difference in postoperative hemoglobin levels, with a mean of 11.4 g/dL in both the TXA and control groups. CONCLUSIONS: These results support the use of intraoperative TXA in tumor resection. However, its role in tumor resection has been less well investigated compared with its use in other areas of neurosurgery.
引用
- Brown NJ, Wilson B, Ong V, et al. Use of Tranexamic Acid for Elective Resection of Intracranial Neoplasms: A Systematic Review. World Neurosurg. 2022. PMID: 34995825. doi:10.1016/j.wneu.2021.12.117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。